ALCAM and neoplasm: In conclusion, our study underscores the clinical significance of loss of E-cadherin and β-catenin membrane expression in relation to ALCAM expression in early precancerous stage (dysplasia), their sustained deregulation in OSCCs and correlation with aggressive tumor behavior and poor prognosis, underscoring their potential as candidate biomarkers for disease prognosis.